Most Read Articles
Pearl Toh, 13 Jan 2018
A study finds no evidence that using pharmaceutical aids alone for smoking cessation helps improve the chances of successful quitting despite promising results in previous randomized trials and routine prescription of such drugs to help quit smoking.
Elvira Manzano, 4 days ago
Cancer patients at risk for recurrent venous thromboembolism (VTE) are less likely to experience recurrence with rivaroxaban compared with dalteparin, the Select-D trial has shown, ushering in a new standard of care (SoC) for cancer-related VTE.
Roshini Claire Anthony, Yesterday

The combination of ceftazidime and avibactam proved noninferior to meropenem in adults with nosocomial pneumonia, positioning it as a potential treatment option for this condition, results from the phase III REPROVE* trial show. Nonetheless, the combination was associated with a higher number of safety events compared with meropenem.

Tristan Manalac, Yesterday
Hormone treatment confers beneficial mood effects in postmenopausal women, according to a recent study, which reports that a transdermal oestradiol plus intermittent micronized progesterone (TE+IMP) treatment regimen is more effective than placebo at reducing depressive symptoms in peri- and postmenopausal women.

Developmental difficulties, sensory defects among children with congenital rubella syndrome

16 May 2017
Most children with congenital rubella syndrome (CRS) experience develop-mental difficulties combined with sensory defects, according to a recent study.

Researchers followed 41 children with CRS, after a large rubella outbreak that occurred in Khanh Hoa Province, Vietnam, in 2011, in order to evaluate the long-term effects of CRS on developmental, ophthalmological, and otological outcomes. By October 2013, 14 participants had died and six could no longer be traced. A total of 21 children were thus followed-up between October 2013 and October 2015. Ophthalmological and otoscopic examinations and automated auditory brainstem response tests were performed on all 21 children in 2013 and were repeated in 16 children in 2015. A test of visual acuity was also performed in 2015.

About, 62 percent (n=13) of children were diagnosed with hearing impairment, while 33 percent (n=7) of children had functional ophthalmological problems other than pigmentary retinopathy. Then, 95 percent (n=19) of children failed in at least one area of the Ages and Stages Questionnaire (ASQ) and/or Denver II test in 2013 and/or 2015, and were suspected of having developmental problems. Communication difficulties (ASQ communication domain and Denver II language area failures) were frequently noted, and autism spectrum disorder (ASD) was suspected in 7 participants in 2013, according to the Modified Checklist for Autism in Toddlers. By 2015, most children continued to experience communication difficulties and a greater proportion failed in the problem-solving and personal-social domains of the ASQ. Two children were diagnosed with severe ASD in 2015.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Pearl Toh, 13 Jan 2018
A study finds no evidence that using pharmaceutical aids alone for smoking cessation helps improve the chances of successful quitting despite promising results in previous randomized trials and routine prescription of such drugs to help quit smoking.
Elvira Manzano, 4 days ago
Cancer patients at risk for recurrent venous thromboembolism (VTE) are less likely to experience recurrence with rivaroxaban compared with dalteparin, the Select-D trial has shown, ushering in a new standard of care (SoC) for cancer-related VTE.
Roshini Claire Anthony, Yesterday

The combination of ceftazidime and avibactam proved noninferior to meropenem in adults with nosocomial pneumonia, positioning it as a potential treatment option for this condition, results from the phase III REPROVE* trial show. Nonetheless, the combination was associated with a higher number of safety events compared with meropenem.

Tristan Manalac, Yesterday
Hormone treatment confers beneficial mood effects in postmenopausal women, according to a recent study, which reports that a transdermal oestradiol plus intermittent micronized progesterone (TE+IMP) treatment regimen is more effective than placebo at reducing depressive symptoms in peri- and postmenopausal women.